68
Golden Throat Holdings Group Company Limited
6896.HK · HKSE
$2.25 -1.10% (-$0.03)
1M -30.49%
Market Cap ¥1.44B
P/E Ratio 5.73x
Div. Yield 14.95%
ROE 19.14%
Bulios Fair Price
$2.68
19.1% upside
Current Price
$2.25
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 6896.HK is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
92 /100
Cheap P/E 5.73x
P/FCF 18.46x
EV/EBITDA 2.87x
Growth
9 /100
Declining EPS growth 3.64%
Book val. growth 3.64%
Rev. growth 1.67%
Profitability
87 /100
Strong Gross margin 76.01%
FCF margin 8.27%
Net margin 26.63%
Quality
71 /100
Excellent ROIC 11.65%
Asset turnover 0.41x
ROE 19.14%
Debt
97 /100
Low Debt/Equity 0.42x
Net debt/EBITDA -1.40x
Current ratio 2.17x
Stability
65 /100
Moderate Beta -0.16x
Profitable years 6
Rev. volatility 21.99%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 6896.HK
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Yong Zeng
Employees
840
Headquarters
Liuzhou